StockData
SMTINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

Sanara MedTech Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$33.14−0.02 (-0.06%)

Close on Oct 19, 2026

Market cap
$287.08M
P/E (TTM)
–
Dividend yield
–

Sanara MedTech Inc. revenue by segment

By business segment

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019% of revenueYoY
Sanara Surgical [Member]–$86.67M$64.99M––––––
THP [Member]––$2.73K––––––

By product or service

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019% of revenueYoY
Soft Tissue Repair Products [Member]$91.35M$76.13M$54.84M$41.65M–––88.6%+20.0%
Bone Fusion Products [Member]$11.77M$10.55M$9.95M$3.99M–––11.4%+11.6%
Royalty Revenue [Member]–––$201.00K$201.00K$201.00K$159.13K––
Product Sales Revenue [Member]––––$23.94M$15.39M$11.61M––
Sanara Legacy Product Sales [Member]–––$45.64M$23.94M––––
Royalty [Member]––$201.00K$201.00K–––––

By region

From the segment and revenue-disaggregation notes of Sanara MedTech's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.